People Living With CF and Managing Treatments

Get to know people with cystic fibrosis (CF) who take KALYDECO® (ivacaftor), and their caregivers, as they share their experiences. The collection of videos below features these individuals discussing why it’s important they take an active role in managing their CF treatments. You’ll also hear stories of the unique ways they’ve handled the challenges of living with CF.

Choose a video below.

Stacy’s Story

Importance of Daily CF Treatments

Making CF Treatments Part of a Routine

Building a Good Partnership

Facing the Journey

Small Steps to CF Management

Taking Responsibility

Transition to Adult Care

What is KALYDECO® (ivacaftor)?

KALYDECO is a prescription medicine used for the treatment of cystic fibrosis (CF) in patients age 2 years and older who have one of the following mutations in their CF gene: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N, or S549R.

KALYDECO is used for the treatment of CF in patients age 2 years and older who have an R117H mutation in their CF gene.

KALYDECO is not for use in people with CF due to other mutations in the CF gene. KALYDECO is not effective in patients with CF with two copies of the F508del mutation (F508del/F508del) in the CF gene.

It is not known if KALYDECO is safe and effective in children under 2 years of age.

Important Safety Information

Who should not take KALYDECO?

Do not take KALYDECO if you take certain medicines or herbal supplements such as: the antibiotics rifampin (Rifamate®, Rifater®) or rifabutin (Mycobutin®); seizure medications such as phenobarbital, carbamazepine (Tegretol®, Carbatrol®, Equetro®) or phenytoin (Dilantin®, Phenytek®); or St. John’s wort.

Talk to your doctor before taking KALYDECO if you take any of these medicines or supplements.